I250=
SynonymousSilentLikely benignCytoplasmic · predictedSilent — Silent — no amino-acid change
Interactive 3D Structure
AlphaFold wild-type wolframin · the variant site near residue 250 (N-terminal cytoplasmic (intrinsically disordered)) is highlighted.
Variant Assessment
Therapeutic Implication · Silent
Clinical Evidence
Not observed in ~730k individuals — consistent with a rare allele (ACMG PM2_supporting).
Feed this card to Wolfram Intelligence
Download the I250= card below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals matched to this Silent synonymous variant and its domain context.
Full Variant Card
I250= — WFS1 Molecular Atlas Card
Variant type: Synonymous (silent) Codon: position 250 (Isoleucine, I) — amino acid unchanged Domain context: N-terminal cytoplasmic (intrinsically disordered)
Schema category: Silent — Silent — no amino-acid change
No amino-acid change (I250 is unchanged): the codon is altered but the protein sequence is identical to wild-type. No structural, stability or AlphaMissense effect applies. Synonymous variants are typically benign unless they affect splicing or regulatory elements; this one is not adjacent to an exon boundary.
Clinical evidence
- Classification: Likely benign
- Review status: criteria provided, single submitter
- cDNA change: c.750C>T
- ClinVar accession: VCV004710883
- Last evaluated: 2025/10/24 00:00
- Submissions: 1
Card generated by wolfram-atlas-batch (synonymous pipeline) on 2026-06-08T02:51:46.905910Z.
WFS1: UniProt O76024, AlphaFold v6. Synonymous variants carry no protein-structural effect.